NICE recommends SGLT-2 inhibitors with metformin at diagnosis, citing major cardiovascular, renal, and mortality benefits.

By Vijay Kumar Malesu Emerging evidence suggests that microbial metabolites not only regulate endogenous GLP-1 secretion but may also influence therapeutic response to GLP-1 receptor agonists, raising ...

For millions of people who live with racing thoughts and a pounding heart, help might already be sitting in the medicine ...

The search for effective and accessible therapies for diabetes continues to draw attention to medicinal plants with a long ...

A widely used diabetes medication may have more medical uses than doctors first thought as scientists discover it may be able to prevent long covid, but there’s a catch. It needs to be taken early in ...

Dr Ellen Fallows answers key questions on the prescribing of medications for weight loss in patients with obesity ...